Alpha Tau Medical Ltd SEC Filings

DRTSW NASDAQ

Welcome to our dedicated page for Alpha Tau Medical SEC filings (Ticker: DRTSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Struggling to decode the dense clinical data, R&D spending tables and warrant disclosures hidden in Alpha Tau Medical’s SEC reports? Biotechnology filings are notorious for complex radiation science terms and multi-phase trial updates that can run well past 200 pages. Stock Titan’s AI-powered analysis turns those technical documents into clear insights—so you can focus on how Alpha DaRT is progressing rather than deciphering footnotes.

Every form filed to EDGAR—whether an Alpha Tau Medical quarterly earnings report 10-Q filing or an Alpha Tau Medical 8-K material events explained alert about new Phase II results—appears here in real time. Our platform provides:

AI summaries that answer “understanding Alpha Tau Medical SEC documents with AI” in seconds
Instant notifications for Alpha Tau Medical Form 4 insider transactions real-time
Side-by-side metrics so cash runway, trial costs and milestone payments are easy to track

Want the specifics? The 10-K gives you a laboratory-level view of Alpha DaRT technology—our tool offers an Alpha Tau Medical annual report 10-K simplified digest that highlights FDA pathway discussions and clinical endpoints. Form 4 pages flag Alpha Tau Medical executive stock transactions Form 4, vital for spotting sentiment before data readouts. Proxy filings cover stock-based incentives—find them under “Alpha Tau Medical proxy statement executive compensation.” Finally, each 8-K headline links straight to AI commentary so you never miss a material development. Whether you’re monitoring Alpha Tau Medical insider trading Form 4 transactions or need quick Alpha Tau Medical earnings report filing analysis, our comprehensive, AI-enhanced hub keeps you informed without sifting through jargon.

06/23/2025 04:56 PM

Filing

[F-3] Alpha Tau Medical Ltd. Warrant Foreign Issuer Shelf Registration

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the current stock price of Alpha Tau Medical (DRTSW)?

The current stock price of Alpha Tau Medical (DRTSW) is $0.2401 as of June 27, 2025.

What is the primary technology developed by Alpha Tau Medical?

Alpha Tau Medical is focused on the development of the Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) technology, which delivers alpha radiation directly to solid tumors via interstitial radioactive seeds.

How does Alpha DaRT technology work?

Alpha DaRT utilizes radium-224 impregnated sources that, once implanted in the tumor, release short-lived alpha-emitting atoms. These atoms irradiate the tumor locally, aiming to destroy cancer cells while preserving healthy tissues.

What types of cancers are being targeted by the company?

The technology is being evaluated in the treatment of various solid tumors, including pancreatic cancer, liver metastases, and recurrent cutaneous squamous cell carcinoma, among others.

In which regions are clinical trials being conducted?

Alpha Tau Medical is running clinical trials internationally, with significant activities in the European Union, North America, and Israel, leveraging collaborations with renowned health centers and research institutions.

What distinguishes Alpha DaRT from traditional radiotherapy?

Unlike traditional radiotherapy, Alpha DaRT targets tumors with high precision by diffusing alpha-emitting atoms directly within the tumor. This localized treatment minimizes damage to surrounding healthy tissue and enhances the therapeutic impact.

How does the company ensure the safety and efficacy of its technology?

Alpha Tau Medical conducts rigorous preclinical and clinical trials in collaboration with established academic institutions and clinical centers to validate the safety, feasibility, and efficacy of its Alpha DaRT technology.

What market segment does Alpha Tau Medical primarily serve?

The company serves the oncology therapeutics market, focusing on innovative treatments for solid tumors through advanced radiotherapy solutions and targeted cancer treatment methodologies.

How does Alpha Tau Medical demonstrate its commitment to scientific integrity?

Through comprehensive clinical evaluations, detailed research collaborations, and transparent communication of clinical trial methodologies and results, Alpha Tau Medical underscores its commitment to rigorous scientific standards and credibility in the oncology field.